{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:05:50Z","timestamp":1773705950409,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-025-02841-x","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T06:57:47Z","timestamp":1746428267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The development of electronic health record\u2014extractable quality indicators for osteoporosis in primary care: A rand-modified Delphi method"],"prefix":"10.1186","volume":"26","author":[{"given":"Elize","family":"Heymans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Segaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Vaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Van den Bulck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"2 suppl.","key":"2841_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"NE Lane","year":"2006","unstructured":"Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2 suppl.):S3-11.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2841_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/M19-0533","volume":"171","author":"HA Fink","year":"2019","unstructured":"Fink HA, MacDonald R, Forte ML, Rosebush CE, Ensrud KE, Schousboe JT, et al. Long-term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: A Systematic Review. Ann Intern Med. 2019;171(1):37\u201350.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2841_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021;16(1):82.","journal-title":"Arch Osteoporos"},{"issue":"7","key":"2841_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1525-1497.2004.30240.x","volume":"19","author":"CA Morris","year":"2004","unstructured":"Morris CA, Cabral D, Cheng H, Katz JN, Finkelstein JS, Avorn J, et al. Patterns of Bone Mineral Density Testing Current Guidelines, Testing Rates, and Interventions. J Gen Intern Med. 2004;19(7):783\u201390.","journal-title":"J Gen Intern Med"},{"key":"2841_CR5","unstructured":"International Osteoporosis Foundation. How fragile is her future? 2000. Available from:https:\/\/www.osteoporosis.foundation\/sites\/iofbonehealth\/files\/2020-04\/how_fragile_is_her_future.pdf"},{"issue":"4","key":"2841_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s001980050224","volume":"10","author":"HK Genant","year":"1999","unstructured":"Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, et al. Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10(4):259\u201364.","journal-title":"Osteoporos Int"},{"issue":"6","key":"2841_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s40954-015-0104-7","volume":"44","author":"F Govaerts","year":"2015","unstructured":"Govaerts F. Val- en fractuurpreventie. Huisarts Nu. 2015;44(6):254\u20135.","journal-title":"Huisarts Nu"},{"issue":"1","key":"2841_CR8","first-page":"116","volume":"21","author":"SA Van Den Bulck","year":"2020","unstructured":"Van Den Bulck SA, Vankrunkelsven P, Goderis G, Van Pottelbergh G, Swerts J, Panis K, et al. Developing quality indicators for Chronic Kidney Disease in primary care, extractable from the Electronic Medical Record. A Rand-modified Delphi method BMC Nephrol. 2020;21(1):116.","journal-title":"A Rand-modified Delphi method BMC Nephrol"},{"issue":"2","key":"2841_CR9","first-page":"16","volume":"2","author":"A Conklin","year":"2012","unstructured":"Conklin A, Yaqub O, Celia C, Nolte E. Postmenopausal osteoporosis management: A review of the evidence to inform the development of quality indicators. Rand Health Q. 2012;2(2):16.","journal-title":"Rand Health Q"},{"issue":"S2","key":"2841_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1532-5415.2007.01347.x","volume":"55","author":"J Grossman","year":"2007","unstructured":"Grossman J, MacLean CH. Quality indicators for the care of osteoporosis in vulnerable elders. J Am Geriatr Soc. 2007;55(S2):392\u2013402.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2841_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/qshc.2007.023226","volume":"17","author":"E Van Der Ploeg","year":"2008","unstructured":"Van Der Ploeg E, Depla MFIA, Shekelle P, Rigter H, Mackenbach JP. Developing quality indicators for general practice care for vulnerable elders; transfer from US to the Netherlands. Qual Saf Health Care. 2008;17(4):291\u20135.","journal-title":"Qual Saf Health Care"},{"key":"2841_CR12","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. RAND\/UCLA appropriateness method user's manual: RAND corporation Santa Monica, CA; 2000."},{"key":"2841_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1748-5908-7-21","volume":"7","author":"T Kotter","year":"2012","unstructured":"Kotter T, Blozik E, Scherer M. Methods for theguideline-based development of quality indicators\u2014asystematic review. Implement Sci. 2012;7:21.","journal-title":"Implement Sci"},{"key":"2841_CR14","unstructured":"National Center for Biotechnology Information (NCBI) . Pubmed. 2024. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/. Cited 2023 Aug 1."},{"key":"2841_CR15","unstructured":"Guidelines international network (GIN). 2024. Available from: https:\/\/guidelines.ebmportal.com\/. Cited 2023 Aug 1"},{"key":"2841_CR16","unstructured":"Turning Research Into Practice (TRIP). 2024. Available from: https:\/\/www.tripdatabase.com\/Home. Cited 2023 Aug 1"},{"key":"2841_CR17","unstructured":"EBPracticenet. 2024;. Available from: https:\/\/ebpnet.be\/nl. Cited 2023 Aug 1"},{"key":"2841_CR18","unstructured":"AGREE Next Steps Consortium. AGREE II. Instrument voor de beoordeling van richtlijnen. 2009. Available from: www.agreetrust.org"},{"key":"2841_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/bcp.12919","volume":"82","author":"J Tichelaar","year":"2016","unstructured":"Tichelaar J, den Uil SH, Antonini NH, van Agtmael MA, de Vries TPGM, Richir MC. A\u2019 SMART\u2019 way to determinetreatment goals in pharmacotherapy education. Br J Clin Pharmacol. 2016;82:280\u20134.","journal-title":"Br J Clin Pharmacol"},{"key":"2841_CR20","unstructured":"Nederlands Huisartsen Genootschap, NHG standaard Fractuurpreventie. 2012. Available from: https:\/\/richtlijnen.nhg.org\/."},{"issue":"139","key":"2841_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.maturitas.2020.05.006","volume":"1","author":"D Sanchez-Rodriguez","year":"2020","unstructured":"Sanchez-Rodriguez D, Bergmann P, Body JJ, Cavalier E, Gielen E, Goemaere S, et al. The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women. Maturitas. 2020;1(139):69\u201389.","journal-title":"Maturitas"},{"issue":"4","key":"2841_CR22","first-page":"379","volume":"27","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al. American association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract. 2020;27(4):379\u201380.","journal-title":"Endocr Pract"},{"key":"2841_CR23","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of osteoporosis and the prevention of fragility fractures A national clinical guideline. Edinburgh; 2021. Available from: https:\/\/www.sign.ac.uk\/ourguidelines\/management-of-osteoporosis-and-the-prevention-of-fragility-fractures\/."},{"issue":"1","key":"2841_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2020","unstructured":"Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, Harvey N, Kanis J, Leyland S, Low R, McCloskey E, Moss K, Parker J, Paskins Z, Poole K, Reid DM, Stone M, Thomson J, Vine N, Compston J. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2020;17(1):58.","journal-title":"Arch Osteoporos"},{"issue":"4","key":"2841_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/AOG.0000000000004730","volume":"139","author":"ACOG Committee on Clinical Practice Guidelines-Gynecology","year":"2022","unstructured":"ACOG Committee on Clinical Practice Guidelines-Gynecology. Management of Postmenopausal Osteoporosis: ACOG Clinical Practice Guideline No. 2. Obstet Gynecol. 2022;139(4):698\u2013717.","journal-title":"Obstet Gynecol."},{"key":"2841_CR26","doi-asserted-by":"crossref","unstructured":"The North American Menopause Society (NAMS). Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28(9):973\u2013997.","DOI":"10.1097\/GME.0000000000001831"},{"issue":"1","key":"2841_CR27","first-page":"10","volume":"43","author":"AM Rodrigues","year":"2018","unstructured":"Rodrigues AM, Canh\u00e3o H, Marques A, Ambr\u00f3sio C, Borges J, Coelho P, et al. Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis \u2013 2018 update. Acta Reumatol Port. 2018;43(1):10\u201331.","journal-title":"Acta Reumatol Port"},{"key":"2841_CR28","unstructured":"National Institute for Health and Care Excellence (NICE). Osteoporosis: assessing the risk of fragility fracture Clinical guideline. 2017. Available from: https:\/\/www.nice.org.uk\/guidance\/cg146\/chapter\/Recommendations."},{"key":"2841_CR29","unstructured":"National Institute for Health and Care Excellence (NICE). Osteoporosis. 2017. Available from: https:\/\/www.nice.org.uk\/guidance\/qs149."},{"key":"2841_CR30","unstructured":"Kaiser permanente. Osteoporosis Screening, Diagnosis, and Treatment Guideline. 2022. Available from: https:\/\/wa.kaiserpermanente.org\/static\/pdf\/public\/guidelines\/osteoporosis.pdf."},{"issue":"4","key":"2841_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.reuma.2018.09.004","volume":"15","author":"A Naranjo Hern\u00e1ndez","year":"2019","unstructured":"Naranjo Hern\u00e1ndez A, D\u00edaz P, Fontecha DC, Pilar M, Ac\u00edn A, Arboleya Rodr\u00edguez L, et al. Recommendations by the Spanish Society of Rheumatology on Osteoporosis. Reumatol Clin. 2019;15(4):188\u2013210.","journal-title":"Reumatol Clin"},{"issue":"8","key":"2841_CR32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033\u201346.","journal-title":"Osteoporos Int"},{"key":"2841_CR33","doi-asserted-by":"publisher","unstructured":"Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: Prospective derivation and validation of QFractureScores. BMJ. 2009;339(b4229):17. Available from: https:\/\/doi.org\/10.1136\/bmj.b4229","DOI":"10.1136\/bmj.b4229"},{"key":"2841_CR34","volume-title":"Wegwijs in laboratoriumdiagnose","author":"X Bossuyt","year":"2016","unstructured":"Bossuyt X. Wegwijs in laboratoriumdiagnose. Leuven: Acco; 2016."},{"key":"2841_CR35","doi-asserted-by":"publisher","unstructured":"Laurent, M. R., Goemaere, S., Verroken, C., Bergmann, P., Body, J. J., Bruy\u00e8re, O., Cavalier, E., Rozenberg, S., Lapauw, B., & Gielen, E. Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club. Front Endocrinol. 2022; 13:908727. Available from: https:\/\/doi.org\/10.3389\/fendo.2022.908727","DOI":"10.3389\/fendo.2022.908727"},{"key":"2841_CR36","doi-asserted-by":"publisher","unstructured":"Steindel S. J. (2010). International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets.\u00a0Journal of the American Medical Informatics Association : JAMIA,\u00a017(3), 274\u2013282. Available from: https:\/\/doi.org\/10.1136\/jamia.2009.001230","DOI":"10.1136\/jamia.2009.001230"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-02841-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-02841-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-02841-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T06:57:59Z","timestamp":1746428279000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-025-02841-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2841"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-02841-x","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the Declaration of Helsinki and was presented to the ethical committee of KULeuven (SCONE) with number MP022081 and approved. Informed consent was given by all participants. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}